T. Rowe Price Associates’s iTeos Therapeutics ITOS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$150K	Buy	14,969 +2,579	+21%	+$25.8K	﹤0.01%	2805
2025 Q1	$74K	Buy	+12,390	New	+$74K	﹤0.01%	2876